Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert C. Penland
Robert C. Penland
Durham University
Placebo
Endocrinology
Biology
Dapagliflozin
Internal medicine
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dapagliflozin Exposure Response in Japanese vs. Non-Japanese Patients with Type 1 Diabetes
2018
Diabetes
Victor Sokolov
Tatiana Yakovleva
Shinya Ueda
Joanna Parkinson
Robert C. Penland
David W. Boulton
Weifeng Tang
Show All
Source
Cite
Save
Citations (0)
Impact of SGLT2 Inhibitors (SGLT2i) on Cardiovascular (CV) Risk and Estimated Glomerular Filtration Rate (eGFR) in the EXSCEL Placebo Group
2018
Diabetes
Lindsay Clegg
Hiddo L. Heerspink
Robert C. Penland
Weifeng Tang
David W. Boulton
Srinivas Bachina
Robert D. Fox
Peter Fenici
Marcus Thuresson
Robert J. Mentz
Adrian F. Hernandez
M. Angelyn Bethel
R R Holman
Show All
Source
Cite
Save
Citations (0)
1